Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Fragile X Syndrome (FXS) is the most common known inherited form of mental impairment,
developmental disability and autism. Minocycline is an antibiotic that has recently been used
to treat the mouse model for Fragile X, and was found to reverse the structural abnormalities
that are seen their brain cells. The purpose of this research study is to determine if
minocycline is an effective treatment for patients with fragile X syndrome (FXS).